How to Keep Patients Committed to GLP-1 Therapy

A physician talking to an overweight woman about GLP-1 therapy adherence

GLP-1 therapy with semaglutide and tirzepatide has become a powerful option for weight management and blood sugar control. However, helping patients stay engaged throughout their treatment can be challenging.

Vigor Compounding supports providers offering compounded GLP-1 therapy options by working with trusted, licensed 503A compounding pharmacy partners. These programs may include compounded semaglutide and tirzepatide formulations, including options with vitamin B6, designed to support patient adherence and comfort when clinically appropriate.

Below are several practical strategies providers can use to help patients remain consistent and successful with GLP-1 therapy.

Key Strategies to Keep Patients Committed

Healthcare practitioners can take several steps to promote consistency. Here are some practical approaches.

Set Realistic Expectations

Patients may expect rapid or dramatic weight loss, but it is important to emphasize that GLP-1 medications work gradually.

Providers should:

  • Educate patients about typical timelines for weight loss and glycemic improvement

  • Make sure patients understand initial side effects may lessen over time

  • Reinforce that long-term success requires ongoing dedication

Personalize Dosage and Titration Plans

Every patient responds differently to GLP-1 therapy. Customizing titration schedules can help patients stay comfortable.

Steps to take include:

  • Starting with smaller doses and increasing slowly when appropriate

  • Observing for side effects and adjusting doses as needed

  • Considering supportive formulation options, such as vitamin B6, when clinically indicated

Provide Ongoing Support and Education

Regular follow-up appointments keep patients motivated and give them a chance to address concerns.

Providers can:

  • Discuss progress and celebrate small victories

  • Share tips on managing side effects

  • Answer questions about compounded versus branded medication options

Address Common Barriers to Adherence

Identifying and resolving obstacles early can reduce treatment discontinuation. Common barriers include:

  • Side Effects: Some patients may benefit from additional supportive measures during therapy initiation

  • Perceived Plateaus: Remind patients that progress may slow, but long-term benefits continue

Encourage Lifestyle Modifications for Better Results

Patients who combine GLP-1 therapy with nutrition and consistent exercise are more likely to see lasting success.

Practitioners should encourage sustainable lifestyle changes and celebrate milestones during follow-up visits.

Empower Your Patients for Long-Term Success

Maintaining patient engagement with GLP-1 therapy requires a proactive, compassionate approach. Providers can significantly enhance adherence and drive better outcomes by following the strategies outlined above.

If you are interested in support resources or guidance on connecting with trusted, licensed 503A compounding pharmacy partners for GLP-1 therapy programs, Vigor Compounding is here to help.

Contact us today at (740) 566-4690 or partnerships@vigorhealth.online.

For Providers

Become a Vigor Partner


* All indicated fields must be completed.
Please include non-medical questions and correspondence only.

For Patients

Start Your Vigor Patient Journey


* All indicated fields must be completed.
Please include non-medical questions and correspondence only.

chat@1.2x

Chat With Sales

SPEAK TO OUR PARTNER TEAM

hq@1.2x

Visit Us

VIGOR HQ

The Drugstore on East State, Ohio 45701

contact@1.2x

Mon-Fri 9am-7pm. Sat 9am-4pm

Accessibility Toolbar